|
Market Closed -
Nasdaq
16:00:00 2026-11-09 EST
|
5-day change | 1st Jan Change | ||
| 919.96 USD | +1.73% |
|
-4.30% | +19.19% |
| Market Cap | 92.32B 82.4B 75.82B 68.82B 130B 8,653B 134B 907B 362B 4,633B 346B 339B 14,591B | P/E 2026 * |
15.5x | P/E 2027 * | 14.8x |
|---|---|---|---|---|---|
| Enterprise Value | 85.15B 76B 69.94B 63.47B 120B 7,981B 123B 837B 333B 4,273B 320B 313B 13,458B | EV / Sales 2026 * |
4.53x | EV / Sales 2027 * | 3.96x |
| Free-Float |
72.57% | Yield 2026 * |
0.41% | Yield 2027 * | 0.44% |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| REGN | Delayed | |
CBOE
| REGN | Real-time | |
|
Mexican S.E.
| REGN * | End-of-day quote | |
|
Tradegate
| RGO | Real-time | |
|
Xetra
| RGO | End-of-day quote | |
|
Boerse Muenchen
| RGO | Real-time | |
|
London S.E.
| 0R2M | Delayed | |
|
Börse Stuttgart
| RGO | Delayed | |
|
Deutsche Boerse AG
| RGO | Delayed | |
|
Borsa Italiana
| 1REGN | End-of-day quote | |
|
Wiener Boerse
| REGN | End-of-day quote | |
|
Lima
| REGNUS | End-of-day quote |
Last Transcript: Regeneron Pharmaceuticals, Inc.
| 1 day | +1.73% | ||
| 1 week | -4.30% | ||
| Current month | -0.85% | ||
| 1 month | +23.23% | ||
| 3 months | +17.29% | ||
| 6 months | +28.69% | ||
| Current year | +19.19% |
| 1 week | 887.04 |  | 991.73 |
| 1 month | 743.57 | | 991.73 |
| Current year | 591.52 | | 991.73 |
| 1 year | 591.52 | | 991.73 |
| 3 years | 476.49 | | 1,211.2 |
| 5 years | 476.49 | | 1,211.2 |
| 10 years | 271.37 | | 1,211.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
| President | 66 | 2000-12-31 | |
| Chief Executive Officer | 73 | 1988-01-07 | |
| Director of Finance/CFO | 55 | 2024-02-04 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 73 | 2023-06-08 | |
Joseph Goldstein
BRD | Director/Board Member | 85 | 1991-05-31 |
George Sing
BRD | Director/Board Member | 76 | 1988-01-07 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 11/4/26 | Exercice | SVP Controller | 11,828 | 0.0117% | ||
| 11/3/26 | Exercice | Director | 22,317 | 0.0221% | ||
| 11/3/26 | Don | Chief Technology Officer | -1,054 | 0.0010% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.73% | -4.30% | +39.91% | +14.96% | 90.75B | |
| +4.28% | +0.07% | +52.75% | +138.78% | 1,206B | |
| +2.13% | +4.27% | +51.21% | +91.36% | 665B | |
| +0.68% | +1.54% | +33.83% | +112.47% | 515B | |
| +2.77% | +0.98% | +49.44% | +68.46% | 381B | |
| +1.38% | +0.27% | +72.42% | +45.30% | 362B | |
| +0.29% | +1.48% | +30.84% | +58.32% | 307B | |
| +0.98% | +1.49% | +9.04% | +34.78% | 289B | |
| +1.04% | -0.05% | +45.29% | +76.18% | 249B | |
| +1.46% | -0.59% | +42.48% | +125.82% | 207B | |
| Average | +1.71% | -0.11% | +42.72% | +76.64% | 427B | |
| Weighted average by Cap. | +2.28% | +0.54% | +45.86% | +94.32% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 18.78B 16.77B 15.43B 14B 26.54B 1,761B 27.19B 185B 73.56B 943B 70.5B 68.99B 2,969B | 20.15B 17.99B 16.55B 15.02B 28.47B 1,889B 29.17B 198B 78.91B 1,011B 75.63B 74.01B 3,185B |
| Net income | 6.43B 5.74B 5.28B 4.79B 9.08B 602B 9.3B 63.14B 25.17B 322B 24.12B 23.6B 1,016B | 6.56B 5.86B 5.39B 4.89B 9.27B 615B 9.5B 64.45B 25.69B 329B 24.62B 24.09B 1,037B |
| Net Debt | -7.17B -6.4B -5.89B -5.34B -10.13B -672B -10.38B -70.43B -28.07B -360B -26.9B -26.33B -1,133B | -12.52B -11.17B -10.28B -9.33B -17.68B -1,173B -18.12B -123B -49.02B -628B -46.98B -45.98B -1,978B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-11-09 | US$919.96 | +1.73% | 856,589 |
| 26-11-06 | US$904.35 | +0.16% | 1,122,872 |
| 26-11-05 | US$902.90 | -2.98% | 1,407,351 |
| 26-11-04 | US$930.67 | -4.39% | 1,395,270 |
| 26-11-03 | US$973.36 | +1.26% | 1,200,307 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- REGN Stock
Select your edition
All financial news and data tailored to specific country editions
